Diffusion-Weighted Magnetic Resonance Imaging in Ovarian Cancer: Exploiting Strengths and Understanding Limitations

Abstract

Detection, characterization, staging, and response assessment are key steps in the imaging pathway of ovarian cancer. The most common type, high grade serous ovarian cancer, often presents late, so that accurate disease staging and response assessment are required through imaging in order to improve patient management. Currently, computerized tomography (CT) is the most common method for these tasks, but due to its poor soft-tissue contrast, it is unable to quantify early response within lesions before shrinkage is observed by size criteria. Therefore, quantifiable techniques, such as diffusion-weighted magnetic resonance imaging (DW-MRI), which generates high contrast between tumor and healthy tissue, are increasingly being explored. This article discusses the basis of diffusion-weighted contrast and the technical issues that must be addressed in order to achieve optimal implementation and robust quantifiable diffusion-weighted metrics in the abdomen and pelvis. The role of DW-MRI in characterizing adnexal masses in order to distinguish benign from malignant disease, and to differentiate borderline from frankly invasive malignancy is discussed, emphasizing the importance of morphological imaging over diffusion-weighted metrics in this regard. Its key role in disease staging and predicting resectability in comparison to CT is addressed, including its valuable use as a biomarker for following response within individual lesions, where early changes in the apparent diffusion coefficient in peritoneal metastases may be detected. Finally, the task of implementing DW-MRI into clinical trials in order to validate this biomarker for clinical use are discussed, along with the trials that include it within their protocols.

Predictive modeling for postoperative delirium in elderly patients with abdominal malignancies using synthetic minority oversampling technique

“…Abdominal malignant tumors, including stomach, colon, liver, gallbladder, and pancreas malignancies, are highly prevalent cancers, particularly impacting the well-being of the elderly[ 11 , 12 ]. Surgical interventions are crucial in managing these tumors, but they bring significant risks.…”

Recent Advances in Nanomaterials-Based Targeted Drug Delivery for Preclinical Cancer Diagnosis and Therapeutics

“…Clinical oncology relies heavily on tumor imaging, with radiological tests able to identify solid tumors, ascertain recurrence, and track therapy outcomes. The primary goal of traditional tumor imaging techniques like CT and MRI is to delineate the morphological characteristics of the tissue, tumor, and organs, including the anatomic site, extent, and tumor size, at different angles of spatial resolution and contrast [113]. Over the past ten years, several monodisperse magnetic nanoparticle preparations have been created for molecular and cellular targeting, cancer staging, immune cell tracking (monocyte/macrophage, T-cell), and angiogenesis imaging [114].…”

Fertility-Preserving Surgery in a Young Nulligravid Woman with Bilateral Coexistence of a Granulosa Cell Tumor with a Teratoma

“…Pham Van Tuyen was responsible for the final diagnosis of the tumor and description of lesions and contributed to postoperative treatment. Nguyen Viet Ha contributed to the analysis and interpretation of data and final approval of the version to Table 1: FIGO staging classification for cancer of the ovary, fallopian tube, and peritoneum [10,11].…”